• Radiation Oncology Journal
• /
• 제2권2호
• /
• pp.287-297
• /
• 1984

The normal intracranial structures are relatively resistant to therapeutic radiation, but may react adversely in a variety of ways, and the damage to nerve tissue may be slow in making its appearance, and once damage has occured the patient recovers slowly and incompletly. Therefore, it is important to consider the possibility of either recurrent tumor or late adverse effect in any patient who has had radiotherapy. The determination o( rnorphological/pathological correlation is very important to the therapeutic radiologist who uses CT scans to define a treatment volume, as well as to the clinician who wishes to explain the patient's clinical state in terms of regress, progression, persistence, or recurrence of tumor or radiation-induced edema or necrosis, The authors are obtained as following results ; 1. The field size(whole CNS, large, intermediate, small field) was variable according to the location and extension of tumor and histopathologic diagnosis, and the tatal tumor dose was 4,000 to 6,000 rads except one of recurred case of 9,100 rads. The duration of follow up CT scan was from 3 months to 5 year 10 months. 2, The histopathologic diagnosis of 9cases were glioblastoma multiforme(3 cases), pineal tumor (3), oligodendroglioma (1), cystic astrocytoma (1), pituitary adenoma (1) and their adverse effects after radiation therapy were brain atrophy (4 cases) , radiation necrosis(2), tumor recurrence with or without calcification (2), radiation·induced infarction (1). 3. The recurrent symptoms after radiation therapy of brain tumor were not always the results of regrowth of neoplasm, but may represent late change of irradiated brain. 4. It must be need that we always consider the accurate treatment planning and proper treatment method to reduce undesirable late adverse effects in treatment of brain tumors.

• Radiation Oncology Journal
• /
• 제11권2호
• /
• pp.205-217
• /
• 1993

In order to evalute the effects of radiation on mammalian neuronal system, we have examined the effect of gamma-ray radiation on the monoamine oxidase (MAO) activity in monoaminergic neurons. Following the whole body irradiation, MAO activity in the rat brain was measured as well as in the liver for the comparative studies between the neuronal and nonneuronal system. The effects of some radiation protectors and sensitizers were also examined in addition to the $O_2$ effect. The results can be summarized as follows. 1) The MAO activity of rat brain was minimally affected by the radiation dose up to 1,700 cGy Radiation dose above 2,500 cGy inhibited the brain MAO activity by no less than $l0\%.$ MAO-A form was found to be particularly sensitive to radiation. The liver MAO was somewhat inhibited (by about $5\%$) but hardly dependent on the dose of radiation. 2) The inhibitory effect on the brain was initiated immediately by the radiation dose of 2,500 cGy. On the contrary, for the liver, the inhibitory effect became apparent only 2 days after irradiation. 3) Two days after a dose of 2,500 cGy, Vmax and Km of the brain mitochondrial MAO decreased. For liver, Vmax decreased while Km increased, which indicates the kinetic patterns for the neuronal and nonneruronal systems are not affected similarly by radiation. 4) The effect of several known radiation protectors and sensitizers on MAO activity was tested ut no definite results were obtained. The level of -SH group increased in some degree upon radiation but not by the compounds. 5) MAO activity was not affected by $O_2$ concentration, while an elevated level of lipid peroxidase was found under the same condition. The results described here indicate that characteristics of MAO, one of the most important central nervous system enzymes, are liable to radiation, which is partially differentiated from the liver MAO. Also indicated are that the -SH groups are hardly related to the effect of radiation but the production of the lipid peroxide seems to be somewhat correlated to the effect of radiation.

• Radiation Oncology Journal
• /
• 제33권1호
• /
• pp.36-41
• /
• 2015

Purpose: To evaluate the incidence and risk factors of post-treatment intracranial hemorrhage of brain metastases from hepatocellular carcinoma (HCC). Materials and Methods: Medical records of 81 patients who have been diagnosed of brain metastases from HCC and underwent surgery, radiosurgery and/or whole brain radiotherapy (WBRT) between January 2000 and December 2013 were retrospectively reviewed. Results: Intracranial hemorrhage was present in 64 patients (79%) at the time of diagnosis. Median value of alpha-fetoprotein (AFP) level was 1,700 ng/mL. The Eastern Cooperative Oncology Group (ECOG) performance status for 20 patients was greater than 2. Fifty-seven patients underwent WBRT and the others were treated with surgery and/or radiosurgery without WBRT. During follow-up, 12 events of intracranial hemorrhage after treatment were identified. Three-month post-treatment hemorrhage rate was 16.1%. Multivariate analyses revealed that ECOG performance status, AFP, and WBRT were associated with post-treatment hemorrhage (p = 0.013, 0.013, and 0.003, respectively). Kaplan-Meier analysis showed that 3-month post-treatment hemorrhage rate of new lesion was higher in patients treated without WBRT, although statistical significance was not reached. (18.6% vs. 4.6%; p = 0.104). Ten of 12 patients with post-treatment hemorrhage died with neurologic cause. Conclusion: WBRT should be considered to prevent post-treatment hemorrhage in the treatment of brain metastases from HCC.

• Journal of Korean Neurosurgical Society
• /
• 제58권2호
• /
• pp.163-166
• /
• 2015

The prophylactic use of phenytoin during and after brain surgery and cranial irradiation is a common measure in brain tumor therapy. Phenytoin has been associated with variety of adverse skin reactions including urticaria, erythroderma, erythema multiforme (EM), Stevens-Johnson syndrome, and toxic epidermal necrolysis. EM associated with phenytoin and cranial radiation therapy (EMPACT) is a rare specific entity among patients with brain tumors receiving radiation therapy while on prophylactic anti-convulsive therapy. Herein we report a 41-year-old female patient with left temporal glial tumor who underwent surgery and then received whole brain radiation therapy and chemotherapy. After 24 days of continous prophylactic phenytoin therapy the patient developed minor skin reactions and 2 days later the patient returned with generalized erythamatous and itchy maculopapuler rash involving neck, chest, face, trunk, extremities. There was significant periorbital and perioral edema. Painful mucosal lesions consisting of oral and platal erosions also occurred and prevented oral intake significantly. Phenytoin was discontinued gradually. Systemic admistration of corticosteroids combined with topical usage of steroids for oral lesions resulted in complete resolution of eruptions in 3 weeks. All cutaneous lesions in patients with phenytoin usage with the radiotherapy must be evoluated with suspicion for EM.

• 대한핵의학회지
• /
• 제2권1호
• /
• pp.59-66
• /
• 1968

Technetium 99m pertechnetate brain scanning were performed in 3 cases of head injury (2 chronic subdural hematomas and 1 acute epidural hematoma), 2 cases of brain abscess and I case of intracerebral hematoma associated with arteriovenous anomaly. In all the cases brain scintigrams showed "hot areas." Literatures on radioisotope scanning of intracranial lesions were briefly reviewed. With the improvement of radioisotope scanner and development of new radiopharmaceuticals brain scanning became a safe and useful screening test for diagnosis of intracranial lesions. Brain scanning can be easily performed even to a moribund patient without any discomfort and risk to the patient which are associated with cerebral angiography or pneumoencephalography. Brain scanning has been useful in diagnosis of brain tumor, brain abscess, subdural hematoma, and cerebral vascular diseases. In 80 to 90% of brain tumors positive scintigrams can be expected. Early studies were done with $^{203}Hg$-Neohydrin or $^{131}I$-serum albumin. With these agents, however, patients receive rather much radiation to the whole body and kidneys. In 1965 Harper introduced $^{99m}Tc$ to reduce radiation dose to the patient and improve statistical variation in isotope scanning.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권13호
• /
• pp.5401-5406
• /
• 2015

Background: Brain metastases are the most common intra-cranial neoplasms. The incidence is on a rise due to advanced imaging techniques. Aims: The objective of the study was to analyse the clinical and demographic profile of patients with brain metastases from primary solid tumors. Materials and Methods: This is a retrospective single institutional study covering 130 consecutive patients with brain metastases from January 2007 to August 2014. Results: Some 64.6% of the patients were females. The majority were in the sixth decade of life. The site of the primary tumor was the lungs in 50.8% of the cases. The overall median time from the diagnosis of the primary malignancy to detection of brain metastases was 21.4 months. Survival was found to be significantly improved in patients with solitary brain lesions when compared to patients with multiple brain metastases, and in patients undergoing surgical excision with or without cranial irradiation when compared to whole brain irradiation alone. The majority of the cases belonged to the recursive partitioning analysis class II group. Whole brain radiation therapy was delivered to 79% of the patients. Conclusions: Most of the patients with brain metastases in the study belonged to recursive partitioning analysis classes II or III, and hence had poor prognosis. Most of the patients in the Indian context either do not satisfy the indications for surgical excision or are incapable of bearing the high cost associated with stereotactic radiosurgery. Treatment should be tailored on an individual basis to all these patients.

• Journal of Korean Neurosurgical Society
• /
• 제52권3호
• /
• pp.193-199
• /
• 2012

Objective : The objective of study is to evaluate the incidence of leptomeningeal carcinomatosis (LMC) in breast cancer patients with parenchymal brain metastases (PBM) and clinical risk factors for the development of LMC. Methods : We retrospectively analyzed 27 patients who had undergone surgical resection (SR) and 156 patients with whole brain radiation therapy (WBRT) as an initial treatment for their PBM from breast cancer in our institution and compared the difference of incidence of LMC according to clinical factors. The diagnosis of LMC was made by cerebrospinal fluid cytology and/or magnetic resonance imaging. Results : A total of 27 patients (14%) in the study population developed LMC at a median of 6.0 months (range, 1.0-50). Ten of 27 patients (37%) developed LMC after SR, whereas 17 of 156 (11%) patients who received WBRT were diagnosed with LMC after the index procedure. The incidence of LMC was significantly higher in the SR group compared with the WBRT group and the hazard ratio was 2.95 (95% confidence interval; 1.33-6.54, p<0.01). Three additional factors were identified in the multivariable analysis : the younger age group (<40 years old), the progressing systemic disease showed significantly increased incidence of LMC, whereas the adjuvant chemotherapy reduce the incidence. Conclusion : There is an increased risk of LMC after SR for PBM from breast cancer compared with WBRT. The young age (<40) and systemic burden of cancer in terms of progressing systemic disease without adjuvant chemotherapy could be additional risk factors for the development of LMC.

• 대한방사선치료학회지
• /
• 제26권2호
• /
• pp.265-272
• /
• 2014

목 적 : 전뇌 방사선 치료 시 산란선으로 인하여 영향을 받는 갑상선의 피폭선량을 감소시키기 위해 차폐체를 사용하여 갑상선의 차폐 효과를 평가하고자 한다. 대상 및 방법 : 갑상선의 피폭선량을 측정하기 위해 선형가속기(Clinac iX. VARIAN, USA)를 이용하여 6 MV X선, 300 cGy를 인체모형팬텀에 대향 2문 조사하였다. 갑상선의 입사표면선량을 측정하기 위해 인체모형팬텀의 10번째 슬라이스 표면에 유리선량계 다섯 개를 1.5 cm 간격으로 위치시킨 후 차폐체 미사용, bismuth 차폐체 사용, 0.5 mmPb 차폐체 사용, 자체 제작한 1.0 mmPb 차폐체를 사용하여 각각 5회씩 측정하여 평균값을 산출하였다. 또한, 같은 위치에서 갑상선 심부선량을 측정하기 위해서 인체모형팬텀의 10번째 슬라이스 2.5 cm 깊이에서 유리선량계 다섯 개를 1.5 cm 간격으로 위치시킨 후 차폐체 미사용, bismuth 차폐체 사용, 0.5 mmPb 차폐체 사용, 자체 제작한 1.0 mmPb 차폐체를 사용하여 각각 5회씩 측정하여 평균값을 산출하였다. 결 과 : 갑상선의 입사표면선량은 차폐체 미사용 시 44.89 mGy로 측정되었고, bismuth 차폐체는 36.03 mGy, 0.5 mmPb 차폐체는 31.03 mGy, 자체 제작한 1.0 mmPb 차폐체는 23.21 mGy로 측정되었다. 또한, 갑상선의 심부선량은 차폐체 미사용 시 36.10 mGy로 측정되었고, bismuth 차폐체는 34.52 mGy, 0.5 mmPb 차폐체는 32.28 mGy, 자체 제작한 1.0 mmPb 차폐체는 25.50 mGy로 측정되었다. 결 론 : 전뇌 방사선 치료 시 방사선 조사면 밖의 영역에서 발생하는 이차 산란 및 누출 선량에 의해 영향을 받는 갑상선에 대하여 차폐체를 사용했을 때 갑상선 심부는 약 11~30%, 갑상선 표면은 약 20~48% 정도의 피폭선량 감소 효과가 나타났다. 따라서 전뇌 방사선 치료 시 갑상선 차폐체를 사용함으로써 갑상선을 효과적으로 보호하며 치료를 시행할 수 있을 것으로 사료된다.

• Radiation Oncology Journal
• /
• 제13권4호
• /
• pp.385-390
• /
• 1995

목적 : 급성 림프모구성 백혈병 (ALL)의 중추신경계 재발시 수막강내 화학요법과 병행한 전뇌척수에 대한 방사선요법의 치료효과와 재발양상을 분석하고자 하였다. 방법 : ALL의 중추신경계 재발로 진단받고 전뇌척수 방사선요법을 시행받은 30 예를 대상으로 치료성적을 분석하였다. 연령분포는 2 세에서 46 세였고 소아환자는 19 예였다. 남녀 각 15 예로 동일하였다. 예방적 전뇌 방사선치료를 시행받은 경우는 22 예, 시행받지 않은 경우가 8 예였다. Co-60 원격치료기를 사용한 방사선요법의 조사범위는 전뇌척수를 (전뇌에 18-24 Gy, 전척수에 12 Gy) 포함하였으나, 전신상태가 좋지않은 9 예에서는 전뇌만 포함하였다. 결과 : 중추신경계 완전관해율은 $100{\%}$ 였다. 재차 재발한 12 예중 ($40{\%}$), 1 예는 중추신경계에서만, 2 예는 중추신경계와 골수에, 9 예는 골수에서만 재발하였다. 처음 ALL 치료후 관해지속기간이 24개월 이상인 경우와 방사선치료범위가 전뇌 및 전척수를 포함한 경우에 중추신경계 관해율이 유의하게 높았다. 생존한 10 예의 관해지속기간은 9-87 개월 (중앙값 58 개월) 이었다. 전 환자의 2 년 생존율은 $31.8{\%}$이었다. 결론 : 급성 림프모구성 백혈병의 중추신경계 재발시 수막강내 화학요법과 병용한 방사선요법시 효과적인 중추신경계 관해유도를 위하여 전뇌척수가 조사범위에 포함되어야 한다.

• Journal of electromagnetic engineering and science
• /
• 제15권3호
• /
• pp.151-157
• /
• 2015

The increasing use of mobile phones has raised public concern about the possible biological effects of radiofrequency electromagnetic field (RF-EMF) exposure on the human brain. To investigate the potential effect of RF-EMF exposure on the brain, we examined the behaviors and hippocampal morphology of C57BL/6 mice after sub-chronic exposure to RF-EMFs with a relatively high SAR level (5.0 W/kg). We applied a 2-hour daily exposure of WCDMA 1,950 MHz using a reverberation chamber that was designed for whole-body exposure for 60 days. In the behavioral tests, RF-EMF did not alter the physical activity or long-term memory of mice. Moreover, no alteration was found in the neuronal and glial cells in the hippocampus by RF-EMFs. In this study, we showed that sub-chronic whole body RF exposure did not produce memory impairment and hippocampal morphological alteration in C57BL/6 mice.